Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 14.38
(0.0%)
CNY 14.38
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 134.59 Million | 318.48 Million | 392.27 Million | 589.09 Million | 67.15 Million | - |
| Cost of Revenue | 86.28 Million | 50.58 Million | 57.17 Million | 73.67 Million | 10.49 Million | 21.06 Million |
| Gross Profit | 48.3 Million | 267.89 Million | 335.09 Million | 515.42 Million | 56.65 Million | -21.06 Million |
| Operating Expenses | 186.4 Million | 189.71 Million | 192.01 Million | 277.98 Million | 81.77 Million | 38.77 Million |
| Selling, General and Administrative Expenses | 90.56 Million | 120.48 Million | 128.83 Million | 233.29 Million | 33.57 Million | 7.3 Million |
| Research and Development Expenses | 15.47 Million | 32.4 Million | 35.25 Million | 28.53 Million | 23.75 Million | 12.07 Million |
| Other Expenses | 82 Million | 36.82 Million | 27.91 Million | 16.16 Million | 24.44 Million | -7366.46 |
| Cost and Expenses | 209.28 Million | 240.3 Million | 249.19 Million | 351.65 Million | 92.27 Million | 38.77 Million |
| Operating Income | -81.67 Million | 95.16 Million | 150.79 Million | 211.74 Million | -25.12 Million | -41.35 Million |
| Interest Expense | 1.89 Million | 1.28 Million | 9.85 Million | 9.64 Million | 2.96 Million | 2.65 Million |
| Income Tax Expense | -15.58 Million | 6.86 Million | 1.54 Million | 55.94 Million | -12.2 Million | -13.35 Million |
| Earnings before Tax | -86.57 Million | 48.4 Million | 84 Million | 210.92 Million | -31.24 Million | -41.36 Million |
| Net Income | -70.99 Million | 41.54 Million | 82.46 Million | 154.97 Million | -19.03 Million | -28.01 Million |
| Earnings Per Share Basic | -0.58 | 0.34 | 0.67 | 1.26 | -0.15 | -0.40 |
| Earnings Per Share Diluted | -0.58 | 0.34 | 0.67 | 1.26 | -0.15 | -0.40 |
| Weighted Average Shares Outstanding | 122.39 Million | 123.2 Million | 123.2 Million | 123.2 Million | 123.2 Million | 70.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 122.39 Million | 123.2 Million | 123.2 Million | 123.2 Million | 123.2 Million | 70.03 Million |
| Gross Margin | 0.36 | 0.84 | 0.85 | 0.87 | 0.84 | - |
| EBIT Margin | -0.41 | 0.39 | 0.46 | 0.45 | -0.03 | - |
| Profit Margin | -0.53 | 0.13 | 0.21 | 0.26 | -0.28 | - |
| EBITDA | -54.8 Million | 79.44 Million | 121.93 Million | 246.39 Million | -4.98 Million | -19.65 Million |
| Earnings Before Tax Margin | -0.61 | 0.30 | 0.38 | 0.36 | -0.37 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 35.61 Million | -1.72 Million | 4.36 Million | 139.96 Million | 19.12 Million | -6.29 Million |
| Cost of Revenue | 12.73 Million | 7.68 Million | 631.04 Thousand | 29.86 Million | 9.18 Million | -1.14 Million |
| Gross Profit | 22.87 Million | -9.41 Million | 3.73 Million | 110.1 Million | 9.94 Million | -5.15 Million |
| Operating Expenses | 33.53 Million | 16.81 Million | 33.25 Million | 221.63 Million | 84.08 Million | 31.41 Million |
| Selling, General and Administrative Expenses | 52.78 Million | 8.32 Million | 29.98 Million | - | -14.78 Million | 47.38 Million |
| Research and Development Expenses | 2.89 Million | 8.48 Million | 3.2 Million | - | 3.42 Million | 5.6 Million |
| Other Expenses | -22.14 Million | -13.11 Thousand | -68.69 Thousand | -221.63 Million | -84.08 Million | 5723.83 |
| Cost and Expenses | 46.27 Million | 24.5 Million | 33.88 Million | 221.63 Million | 84.08 Million | 30.26 Million |
| Operating Income | -14.6 Million | -24.5 Million | -29.52 Million | -81.67 Million | -64.96 Million | -57.44 Million |
| Interest Expense | 330.72 Thousand | 458.36 Thousand | 436.87 Thousand | 1.89 Million | 517.75 Thousand | 547.59 Thousand |
| Income Tax Expense | -2.41 Million | -3.47 Million | -4.34 Million | -15.58 Million | -9.34 Million | -11.28 Million |
| Earnings before Tax | -15 Million | -22.85 Million | -25.83 Million | -82.48 Million | -65.16 Million | -57.44 Million |
| Net Income | -12.59 Million | -19.37 Million | -21.49 Million | -65.77 Million | -54.7 Million | -46.15 Million |
| Earnings Per Share Basic | -0.10 | -0.16 | -0.17 | - | -0.44 | -0.37 |
| Earnings Per Share Diluted | -0.10 | -0.16 | -0.17 | - | -0.44 | -0.37 |
| Weighted Average Shares Outstanding | 123.2 Million | 123.2 Million | 123.2 Million | 122.39 Million | 124.11 Million | 123.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 123.2 Million | 123.2 Million | 123.2 Million | 122.39 Million | 124.11 Million | 123.2 Million |
| Gross Margin | 0.64 | 5.44 | 0.86 | 0.79 | 0.52 | 0.82 |
| EBIT Margin | -0.41 | 9.78 | -5.65 | - | -1.72 | 4.95 |
| Profit Margin | -0.35 | 11.20 | -4.92 | -0.47 | -2.86 | 7.33 |
| EBITDA | -14.67 Million | -16.92 Million | -24.66 Million | - | -32.8 Million | -31.18 Million |
| Earnings Before Tax Margin | -0.41 | 14.16 | -6.76 | -0.58 | -3.40 | 9.12 |
2001
4180
6712
VPHIF
VNUE
PTMP